{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:12:54Z","timestamp":1775207574683,"version":"3.50.1"},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.1027","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T06:01:30Z","timestamp":1132293690000},"page":"1027-1032","source":"Crossref","is-referenced-by-count":16,"title":["New Classification and Treatment for Myotonic Disorders"],"prefix":"10.2169","volume":"44","author":[{"given":"Teruyuki","family":"KURIHARA","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Landau WM. The essential mechanism in myotonia. An electromyographic study. Neurology <b>2<\/b>: 369-388, 1952.","DOI":"10.1212\/WNL.2.9-10.369"},{"key":"2","unstructured":"2) Kurihara T. The mechanism of myotonia: Electrophysiological study of induced myotonia using anthracene-9-carboxylic acid. Rihsho Shinkeigaku <b>18<\/b>: 332-338, 1978 (in Japanese)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kurihara T, Brooks JE. Excitation-contraction uncoupling: The effect of hyperosmolar glycerol solution and dantrolene sodium on mammalian muscle in vitro. Arch Neurol <b>32<\/b>: 92-97, 1975.","DOI":"10.1001\/archneur.1975.00490440042006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kurihara T, Brooks JE. The mechanism of neruromuscular fatigue. A study of mammalian muscle using excitation-contraction uncoupling. Arch Neurol <b>32<\/b>: 168-174, 1975.","DOI":"10.1001\/archneur.1975.00490450048006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lipicky RJ, Bryant SH, Salmon JH. Cable parameters, sodium, potassium, chloride, and water content, and potassium efflux in isolated external intercostals muscle of normal volunteers and patients with myotonia congenita. J Clin Invest <b>50<\/b>: 2091-2103, 1971.","DOI":"10.1172\/JCI106703"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lehmann-Horn F, R&uuml;del R, Ricker K. Membrane defects in paramyotonia congenital (Eulenburg). Muscle Nerve <b>10<\/b>: 633-641, 1987.","DOI":"10.1002\/mus.880100709"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ebers GC, George AL, Barchi RL, et al. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene. Ann Neurol <b>30<\/b>: 810-816, 1991.","DOI":"10.1002\/ana.410300610"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ptacek LJ, Gouw L, Kwiecinski H, et al. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol <b>33<\/b>: 300-307, 1993.","DOI":"10.1002\/ana.410330312"},{"issue":"4983","key":"9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","volume":"250","year":"1990","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/354387a0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) R&uuml;del R, Ricker K, Lehmann-Horn F. Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol <b>50<\/b>: 1241-1248, 1993.","DOI":"10.1001\/archneur.1993.00540110113011"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90154-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ricker K, Koch MC, Lehmann-Horn F, et al. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology <b>44<\/b>: 1448-1452, 1994.","DOI":"10.1212\/WNL.44.8.1448"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Schneider C, Ziegler A, Ricker K, et al. Proximal myotonic myopathy. Evidence for anticipation in families with linkage to chromosome 3q. Neurology <b>55<\/b>: 383-388, 2000.","DOI":"10.1212\/WNL.55.3.383"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Finsterer J. Myotonic dystrophy type 2. Eur J Neurol <b>9<\/b>: 441-447, 2002.","DOI":"10.1046\/j.1468-1331.2002.00453.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mankodi A, Takahashi MP, Jiang H, et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell <b>10<\/b>: 35-44, 2002.","DOI":"10.1016\/S1097-2765(02)00563-4"},{"key":"17","unstructured":"17) Harper PS. Myotonic disorders. <i>in<\/i>: Myology. First ed. Engel AG, Banker BQ, Eds. McGraw-Hill, New York, 1986: 1267-1311."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ricker K, Moxley RT 3rd, Heine R, et al. Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol <b>51<\/b>: 1095-1102, 1994.","DOI":"10.1001\/archneur.1994.00540230033009"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sugino M, Ohsawa N, Ito T, et al. A pilot study of dehydroepiandroserone sulfate in myotonic dystrophy. Neurology <b>51<\/b>: 586-589, 1998.","DOI":"10.1212\/WNL.51.2.586"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tarnopolsky M, Mahoney D, Thompson T, et al. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1. Muscle Nerve <b>29<\/b>: 51-58, 2004.","DOI":"10.1002\/mus.10527"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Schneider-Gold C, Beck M, Wessig C, et al. Creatine monohydrate in DM2\/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy. Neurology <b>60<\/b>: 500-502, 2003.","DOI":"10.1212\/01.WNL.0000044405.29988.E1"},{"key":"22","unstructured":"22) Matsumura T, Yokoe M, Nakamori M, et al. A clinical trial of creatine monohydrate in muscular dystorophy patients. Rinsho Shinkeigaku <b>44<\/b>: 661-666, 2004 (in Japanese)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bensoussan L, De Saint Jean M, Lozato P, et al. Severe bilateral capsulorhexis contraction after cataract surgery in myotonic dystrophy: a case report. J Fr Ophthalmol <b>27<\/b>: 479-483, 2004.","DOI":"10.1016\/S0181-5512(04)96167-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Burnstine MA, Putterman AM. Management of myopathic ptosis. Ophthalmology <b>111<\/b>: 411, 2004.","DOI":"10.1016\/j.ophtha.2003.12.012"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lazarus A, Varin J, Babuty D, et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing. A multicenter diagnostic pacemaker study. J Am Coll Cardiol <b>40<\/b>: 1645-1652, 2002.","DOI":"10.1016\/S0735-1097(02)02339-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kouki T, Takasu N, Nakachi A, et al. Low-dose metformin improves hyperglycemia related myotonic dystrophy. Diabet Med <b>22<\/b>: 346-347, 2004.","DOI":"10.1111\/j.1464-5491.2005.01432.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) MacDonald JR, Hill JD, Tarnopolsky MA. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology <b>59<\/b>: 1876-1880, 2002.","DOI":"10.1212\/01.WNL.0000037481.08283.51"},{"key":"28","unstructured":"28) Casasa JM, Isnard RM, Ojanguren I, et al. Intestinal myopathy in Steinert&rsquo;s disease. Cir Pediatr <b>16<\/b>: 149-151, 2003."},{"key":"29","unstructured":"29) Suzuki H, Aoyagi M. Anesthetic management with a laryngeal mask airway for gastrectomy in a patient with myotonic dystrophy. Masui <b>52<\/b>: 993-995, 2003 (in Japanese)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Furling D, Doucet G, Langlois MA, et al. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther <b>10<\/b>: 795-802, 2003.","DOI":"10.1038\/sj.gt.3301955"},{"issue":"21","key":"31","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1093\/nar\/gkh976","volume":"32","author":"HASHEM V I","year":"2004","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1048","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/10\/44_10_1027\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:22:53Z","timestamp":1621444973000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/10\/44_10_1027\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.1027","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}